Risultati per: È confermato il legame tra la malattia di Alzheimer e microbiota intestinale

La scoperta apre la strada all’identificazione di un biomarcatore per la diagnosi precoce e a future vie terapeutiche

Utile per nuove terapie e diagnosi precoce

This Medical News article is an interview about the latest findings presented at the recent Alzheimer’s Association International Conference.

Objective
To decipher the mechanisms by which the major human milk oligosaccharide (HMO), 2’-fucosyllactose (2’FL), can affect body weight and fat mass gain on high-fat diet (HFD) feeding in mice. We wanted to elucidate whether 2’FL metabolic effects are linked with changes in intestinal mucus production and secretion, mucin glycosylation and degradation, as well as with the modulation of the gut microbiota, faecal proteome and endocannabinoid (eCB) system.

Results
2’FL supplementation reduced HFD-induced obesity and glucose intolerance. These effects were accompanied by several changes in the intestinal mucus layer, including mucus production and composition, and gene expression of secreted and transmembrane mucins, glycosyltransferases and genes involved in mucus secretion. In addition, 2’FL increased bacterial glycosyl hydrolases involved in mucin glycan degradation. These changes were linked to a significant increase and predominance of bacterial genera Akkermansia and Bacteroides, different faecal proteome profile (with an upregulation of proteins involved in carbon, amino acids and fat metabolism and a downregulation of proteins involved in protein digestion and absorption) and, finally, to changes in the eCB system. We also investigated faecal proteomes from lean and obese humans and found similar changes observed comparing lean and obese mice.

Conclusion
Our results show that the HMO 2’FL influences host metabolism by modulating the mucus layer, gut microbiota and eCB system and propose the mucus layer as a new potential target for the prevention of obesity and related disorders.

Sindrome di Leigh,progetto vincitore bando Multi-round Telethon

Per l’amaurosi congenita di Leber risultati duraturi e notevoli

Apportare cambiamenti nello stile di vita

Al via campagna. L’8 settembre Giornata Mondiale Fisioterapia

Dalla fine della terapia non ha presentato segni clinici

Advanz Pharma, decisione mette a rischio migliaia di pazienti

Nuovi bersagli. Grazie all’intelligenza artificiale e al machine learning si cercano vie alternative contro l’accumulo delle proteine e per rallentare la malattia

Condizione rara, ma grave, causata da depositi di proteine anomale

Cos’è e come si manifesta la patologia che ha colpito il noto fotografo Oliviero Toscani

Insorge la stampa popolare dei tabloid: ‘Perché solo ai ricchi?’

In a highly publicized study from Sweden, sensitivity and specificity were both about 90%.